Aberrant expression of microRNAs in serum may identify individuals with pancreatic cancer

International Journal of Clinical and Experimental Medicine

Volumn 7, Issue 12, 2014, Pages 5226-5234

  Lin, Mao Song ^a   Chen, Wei Chang ^b   Huang, Jun Xing ^a   Gao, Heng Jun ^c,d   Sheng, Hai Hui ^d  

^a Taizhou People's Hospital   (China)

^b SOOCHOW UNIVERSITY   (China)

^c TONGJI HOSPITAL OF TONGJI UNIVERSITY   (China)

^d Key Laboratory of Health and Disease Genomics   (China)

Author keywords

microRNA; miR 492; miR 663a; Pancreatic cancer; Serum

Indexed keywords

BIOLOGICAL MARKER; MICRORNA; MICRORNA 492; MICRORNA 663A; UNCLASSIFIED DRUG;

ADULT; AREA UNDER THE CURVE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CANCER STAGING; CANCER SURVIVAL; CLINICAL ARTICLE; CLINICAL ASSESSMENT; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIAGNOSTIC VALUE; FEMALE; GENE EXPRESSION; HISTOLOGY; HUMAN; HUMAN TISSUE; MALE; MICROARRAY ANALYSIS; MICRORNA BLOOD LEVEL; PANCREAS CANCER; PILOT STUDY; REAL TIME POLYMERASE CHAIN REACTION; RECEIVER OPERATING CHARACTERISTIC; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ANALYSIS; RNA ISOLATION; SENSITIVITY AND SPECIFICITY; VALIDATION PROCESS;

EID: 84921447733     PISSN: None     EISSN: 19405901     Source Type: Journal    
DOI: None     Document Type: Article

References (39)

1. Garcea G, Neal CP, Pattenden CJ, Steward WP and Berry DP. Molecular prognostic markers in pancreatic cancer: a systematic review. Eur J Cancer 2005; 41: 2213-2236.
2. Hariharan D, Saied A and Kocher HM. Analysis of mortality rates for pancreatic cancer across the world. HPB (Oxford) 2008; 10: 58-62.
3. Benson AB 3rd. Adjuvant therapy for pancreatic cancer: one small step forward. JAMA 2007; 297: 311-313.
4. Carpelan-Holmstrom M, Nordling S, Pukkala E, Sankila R, Luttges J, Kloppel G and Haglund C. Does anyone survive pancreatic ductal adenocarcinoma? A nationwide study re-evaluating the data of the Finnish Cancer Registry. Gut 2005; 54: 385-387.
5. Katz MH, Hwang R, Fleming JB and Evans DB. Tumor-node-metastasis staging of pancreatic adenocarcinoma. CA Cancer J Clin 2008; 58: 111-125.
6. Nieto J, Grossbard ML and Kozuch P. Metastatic pancreatic cancer 2008: is the glass less empty? Oncologist 2008; 13: 562-576.
7. Sultana A, Smith CT, Cunningham D, Starling N, Neoptolemos JP and Ghaneh P. Meta-analyses of chemotherapy for locally advanced and metastatic pancreatic cancer. J Clin Oncol 2007; 25: 2607-2615.
8. Brenner H, Chang-Claude J, Seiler CM, Rickert A and Hoffmeister M. Protection from colorectal cancer after colonoscopy: a population-based, case-control study. Ann Intern Med 2011; 154: 22-30.
9. Moss SM, Cuckle H, Evans A, Johns L, Waller M, Bobrow L and Trial Management G. Effect of mammographic screening from age 40 years on breast cancer mortality at 10 years’ follow-up: a randomised controlled trial. Lancet 2006; 368: 2053-2060.
10. Henschke CI, Boffetta P, Gorlova O, Yip R, Delancey JO and Foy M. Assessment of lung-cancer mortality reduction from CT Screening. Lung Cancer 2011; 71: 328-332.
11. Smith RA, Cokkinides V and Eyre HJ. Cancer screening in the United States, 2007: a review of current guidelines, practices, and prospects. CA Cancer J Clin 2007; 57: 90-104.
12. Goonetilleke KS and Siriwardena AK. Syste-matic review of carbohydrate antigen (CA 19-9) as a biochemical marker in the diagnosis of pancreatic cancer. Eur J Surg Oncol 2007; 33: 266-270.
13. Mora J, Urgell E, Farre A, Comas L, Montserrat E and Gonzalez-Sastre F. Agreement between K-ras sequence variations detected in plasma and tissue DNA in pancreatic and colorectal cancer. Clin Chem 2006; 52: 1448-1449.
14. Moniaux N, Andrianifahanana M, Brand RE and Batra SK. Multiple roles of mucins in pancreatic cancer, a lethal and challenging malignancy. Br J Cancer 2004; 91: 1633-1638.
15. Bartel DP. MicroRNAs: genomics, biogenesis, mechanism, and function. Cell 2004; 116: 281-297.
16. Hu X, Schwarz JK, Lewis JS Jr, Huettner PC, Rader JS, Deasy JO, Grigsby PW and Wang X. A microRNA expression signature for cervical cancer prognosis. Cancer Res 2010; 70: 1441-1448.
17. Lin M, Chen W, Huang J, Gao H, Ye Y, Song Z and Shen X. MicroRNA expression profiles in human colorectal cancers with liver metastases. Oncol Rep 2011; 25: 739-747.
18. Mitchell PS, Parkin RK, Kroh EM, Fritz BR, Wyman SK, Pogosova-Agadjanyan EL, Peterson A, Noteboom J, O’Briant KC, Allen A, Lin DW, Urban N, Drescher CW, Knudsen BS, Stirewalt DL, Gentleman R, Vessella RL, Nelson PS, Martin DB and Tewari M. Circulating microRNAs as stable blood-based markers for cancer detection. Proc Natl Acad Sci U S A 2008; 105: 10513-10518.
19. Song MY, Pan KF, Su HJ, Zhang L, Ma JL, Li JY, Yuasa Y, Kang D, Kim YS and You WC. Identification of serum microRNAs as novel non-invasive biomarkers for early detection of gastric cancer. PLoS One 2012; 7: e33608.
20. Shen J, Todd NW, Zhang H, Yu L, Lingxiao X, Mei Y, Guarnera M, Liao J, Chou A, Lu CL, Jiang Z, Fang H, Katz RL and Jiang F. Plasma microRNAs as potential biomarkers for non-small-cell lung cancer. Lab Invest 2011; 91: 579-587.
21. Heneghan HM, Miller N, Lowery AJ, Sweeney KJ, Newell J and Kerin MJ. Circulating microRNAs as novel minimally invasive biomarkers for breast cancer. Ann Surg 2010; 251: 499-505.
22. Lawrie CH, Gal S, Dunlop HM, Pushkaran B, Liggins AP, Pulford K, Banham AH, Pezzella F, Boultwood J, Wainscoat JS, Hatton CS and Harris AL. Detection of elevated levels of tumour-associated microRNAs in serum of patients with diffuse large B-cell lymphoma. Br J Haematol 2008; 141: 672-675.
23. Resnick KE, Alder H, Hagan JP, Richardson DL, Croce CM and Cohn DE. The detection of differentially expressed microRNAs from the serum of ovarian cancer patients using a novel real-time PCR platform. Gynecol Oncol 2009; 112: 55-59.
24. Shen J, Hruby GW, McKiernan JM, Gurvich I, Lipsky MJ, Benson MC and Santella RM. Dysregulation of circulating microRNAs and prediction of aggressive prostate cancer. Prostate 2012; 72: 1469-1477.
25. Schrauder MG, Strick R, Schulz-Wendtland R, Strissel PL, Kahmann L, Loehberg CR, Lux MP, Jud SM, Hartmann A, Hein A, Bayer CM, Bani MR, Richter S, Adamietz BR, Wenkel E, Rauh C, Beckmann MW and Fasching PA. Circulating micro-RNAs as potential blood-based markers for early stage breast cancer detection. PLoS One 2012; 7: e29770.
26. Liu H, Zhu L, Liu B, Yang L, Meng X, Zhang W, Ma Y and Xiao H. Genome-wide microRNA profiles identify miR-378 as a serum biomarker for early detection of gastric cancer. Cancer Lett 2012; 316: 196-203.
27. Morimura R, Komatsu S, Ichikawa D, Takeshita H, Tsujiura M, Nagata H, Konishi H, Shiozaki A, Ikoma H, Okamoto K, Ochiai T, Taniguchi H and Otsuji E. Novel diagnostic value of circulating miR-18a in plasma of patients with pancreatic cancer. Br J Cancer 2011; 105: 1733-1740.
28. Wang J, Chen J, Chang P, LeBlanc A, Li D, Abbruzzesse JL, Frazier ML, Killary AM and Sen S. MicroRNAs in plasma of pancreatic ductal adenocarcinoma patients as novel blood-based biomarkers of disease. Cancer Prev Res (Phila) 2009; 2: 807-813.
29. Ali S, Almhanna K, Chen W, Philip PA and Sarkar FH. Differentially expressed miRNAs in the plasma may provide a molecular signature for aggressive pancreatic cancer. Am J Transl Res 2010; 3: 28-47.
30. Raver-Shapira N, Marciano E, Meiri E, Spector Y, Rosenfeld N, Moskovits N, Bentwich Z and Oren M. Transcriptional activation of miR-34a contributes to p53-mediated apoptosis. Mol Cell 2007; 26: 731-743.
31. Schepeler T, Reinert JT, Ostenfeld MS, Christensen LL, Silahtaroglu AN, Dyrskjot L, Wiuf C, Sorensen FJ, Kruhoffer M, Laurberg S, Kauppinen S, Orntoft TF and Andersen CL. Diagnostic and prognostic microRNAs in stage II colon cancer. Cancer Res 2008; 68: 6416-6424.
32. Patella F, Leucci E, Evangelista M, Parker B, Wen J, Mercatanti A, Rizzo M, Chiavacci E, Lund AH and Rainaldi G. MiR-492 impairs the angiogenic potential of endothelial cells. J Cell Mol Med 2013; 17: 1006-1015.
33. Schultz NA, Werner J, Willenbrock H, Roslind A, Giese N, Horn T, Wojdemann M and Johansen JS. MicroRNA expression profiles associated with pancreatic adenocarcinoma and ampullary adenocarcinoma. Mod Pathol 2012; 25: 1609-1622.
34. Langenberger D, Cakir MV, Hoffmann S and Stadler PF. Dicer-processed small RNAs: rules and exceptions. J Exp Zool B Mol Dev Evol 2013; 320: 35-46.
35. Long C, Jiang L, Wei F, Ma C, Zhou H, Yang S, Liu X and Liu Z. Integrated miRNA-mRNA analysis revealing the potential roles of miRNAs in chordomas. PLoS One 2013; 8: e66676.
36. Hunter MP, Ismail N, Zhang X, Aguda BD, Lee EJ, Yu L, Xiao T, Schafer J, Lee ML, Schmittgen TD, Nana-Sinkam SP, Jarjoura D and Marsh CB. Detection of microRNA expression in human peripheral blood microvesicles. PLoS One 2008; 3: e3694.
37. Valadi H, Ekstrom K, Bossios A, Sjostrand M, Lee JJ and Lotvall JO. Exosome-mediated transfer of mRNAs and microRNAs is a novel mechanism of genetic exchange between cells. Nat Cell Biol 2007; 9: 654-659.
38. Turchinovich A, Weiz L, Langheinz A and Burwinkel B. Characterization of extracellular circulating microRNA. Nucleic Acids Res 2011; 39: 7223-7233.
39. Wang K, Zhang S, Weber J, Baxter D and Galas DJ. Export of microRNAs and microRNA-protective protein by mammalian cells. Nucleic Acids Res 2010; 38: 7248-7259.